Influence of Anesthesia Technique on Postoperative Evolution After Urogenital Surgical Interventions (ROBOTNGAL)
Anesthesia; Reaction, Adverse Effect of Other General Anesthetics, Adverse Anesthesia Outcome
About this trial
This is an interventional prevention trial for Anesthesia; Reaction
Eligibility Criteria
Inclusion Criteria:
- signed the informed consent without previous renal function alteration respiratory and hemodynamic stability
Exclusion Criteria:
- refuse to sign the informed consent chronic or and stage renal disease severe systemic diseases
Sites / Locations
- City Clinical Hospital Cluj Urology and ICU DepartmentsRecruiting
Arms of the Study
Arm 1
Arm 2
Active Comparator
Experimental
robot general anesthesia
robot combined anesthesia
General anesthesia for robot assisted laparoscopic urogenital surgery includes premedication with alprazolam (0.5 mg per os), induction with sufentanil, propofol (1-2 mg/kg), neuromuscular blocking agents (rocuronium 0.5 mg/kg) to facilitate tracheal intubation. Anesthesia is maintained with volatile agents (sevoflurane, desflurane) and reinjection of rocuronium and sufentanil as needed. Robotic assisted laparoscopic interventions are realised with Da Vinci surgical robot, known to assure a minimally invasive approach with good results in urologic surgery. The system consists of an ergonomic surgeon console, a patient cart with four interactive robotic arms, a 3D high resolution visualization interface and specific EndoWrist articulated tools.
Combined anesthesia is defined as association of epidural analgesia to general anesthesia. Epidural catheter is inserted at low thoracic level in the operation theatre before the induction of anesthesia. Correct position is verified with 15 mg bupivacaine plain 0.5%. Infusion is started after the incision at a rate of 6-8 ml/ hour.Epidural continuous infusion of local anesthetic is maintained 12 hours postoperative in the postoperative anesthesia care unit.